UNSPSC 51284012: Minocycline

This classification denotes a tetracycline antibiotic with the molecular formula C23H27N3O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FYY3R43WGO, chemically known as 4,7-bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide but generally known as minocycline, which bears US NIH Compound Identifier 5281021. European Medicines Agency schedules Minocycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08980MIG.

UNSPSC 51284012 Minocycline is a Commodity code that nominally identifies a specific tetracycline antibiotic, but recent state and local procurement activity shows no current solicitations or awarded contracts for minocycline itself. The two most recent opportunities tagged to this code involve unrelated pharmaceutical products: the Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC; and Seminole County, Florida released an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually. Neither opportunity is purchasing minocycline. The mismatch suggests these opportunities may be incorrectly coded or the code is used for broader pharmaceutical inventory categories by state and local systems.

The issuing bodies on file span a state health department and a county health system, reflecting the typical buyers of pharmaceutical supplies. The geographic activity appears concentrated in Florida and Illinois based on recent postings, though the limited opportunity volume and coding mismatch make reliable geographic characterization difficult. Firms should verify with Illinois Department of Public Health (contact Mike Caceres, 217-577-7905) and Seminole County procurement offices whether minocycline-specific contracts are managed under this code or whether procurement activity has shifted to related therapeutic categories or cooperative purchasing arrangements not yet visible in current filings.